Associations between fine particulate matter and changes in lipids/lipoproteins among midlife women

Fine particles (PM2.5) are known to increase risks of cardiovascular diseases, but it is unclear how they affect plasma lipid levels. In this study, we examined the associations between PM2.5 exposure and lipid/lipoprotein levels from 2289 midlife women enrolled in the longitudinal Study of Women�...

Full description

Saved in:
Bibliographic Details
Published in:The Science of the total environment 2019-03, Vol.654, p.1179-1186
Main Authors: Wu, Xiangmei (May), Broadwin, Rachel, Basu, Rupa, Malig, Brian, Ebisu, Keita, Gold, Ellen B., Qi, Lihong, Derby, Carol, Park, Sung Kyun, Green, Shelley
Format: Article
Language:English
Subjects:
Air Pollutants - analysis
Air Pollution - statistics & numerical data
Cardiovascular Diseases - epidemiology
Cholesterol, HDL
Dyslipidemia
Environmental Exposure - statistics & numerical data
Lipoprotein
Lipoproteins
Long-term exposure
Longitudinal Studies
Menopause
Particulate Matter - analysis
PM2.5
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fine particles (PM2.5) are known to increase risks of cardiovascular diseases, but it is unclear how they affect plasma lipid levels. In this study, we examined the associations between PM2.5 exposure and lipid/lipoprotein levels from 2289 midlife women enrolled in the longitudinal Study of Women's Health Across the Nation. The average exposure to PM2.5 and gaseous co-pollutants during the prior one year, six months, 30 days, and one day were estimated for each woman based on U.S. Environmental Protection Agency ambient monitoring data. Blood samples were collected annually from 1999 to 2005 and analyzed for lipids/lipoproteins. Mixed-effect models were used to account for repeated measures for each woman, adjusted for demographic, health and behavior covariates. PM2.5 exposures, especially the long-term exposure, were negatively associated with protective lipoproteins, and positively associated with atherogenic lipoproteins. For example, each 3 μg/m3 increase of one-year PM2.5 exposure was associated with decreases of −0.7% (−1.4%, −0.1%) in high-density lipoprotein cholesterols and −0.6% (−1.1%, −0.1%) in apolipoprotein A1 (ApoA1), as well as increases of 3.8% (1.0%, 6.6%) in lipoprotein(a) and 1.4% (0.5%, 2.3%) in the ratio of apolipoprotein B (ApoB)/ApoA1. In stratified analysis, increased atherogenic lipoproteins were mainly observed in women without dyslipidemia, and both increased atherogenic lipoproteins and reduced protective lipoproteins were observed among women in perimenopause. In summary, PM2.5 exposure was associated with adverse lipid level changes, and thus, may increase cardiovascular risks in midlife women. [Display omitted] •We examined the associations of ambient PM2.5 exposure with lipids/lipoproteins.•PM2.5 exposures could increase atherogenic and reduce protective lipoproteins.•Most of the adverse impact was observed in long-term exposure windows.•PM2.5 influenced different lipoproteins depending on one's health status.•Long-term exposure to ambient PM2.5 may increase CVD risks in midlife women.
ISSN:0048-9697
1879-1026
DOI:10.1016/j.scitotenv.2018.11.149